Ginkgo Biloba Extract and the Insulin Resistance Syndrome

Completed · Phase 1/Phase 2

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to examine whether the ingestion of the herbal dietary supplement Ginkgo biloba extract has any effect on the efficacy of three classes of diabetic medications - (Glucotrol, Glucophage and Actose). Additionally, the study will examine the effect of Ginkgo biloba extract on pancreatic insulin production in non-diabetic subjects between the ages of 20 and 75 years old.

Key facts

Study ID

NCT00032474

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

150

Starts

2001-12-01

Expected to finish

2005-05-01

Last updated by the study team

2006-08-18

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of type 2 diabetes mellitus and taking oral diabetes medications - Glucotrol, Glucophage and Actose or Avandia
• Must be able to swallow
• Healthy individuals without diabetes aged 20 to 80 years of age

You may not qualify if…

• Type 1 diabetes mellitus
• Type 2 diabetes mellitus taking insulin injections
• Regular use of anti-inflammatory drugs
• Chronic anemia

Where it is running

• University of Texas Health Sciences Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.